A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213
Open Access
- 1 April 1975
- Vol. 35 (4) , 1141-1144
- https://doi.org/10.1002/1097-0142(197504)35:4<1141::aid-cncr2820350418>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- Human anticancer effect of podophyllum derivatives (SPG and SPI): a preliminary report.British Journal of Cancer, 1967